Company Filing History:
Years Active: 2010-2012
Title: Elizabeth Margaret Moir: Innovator in Pharmaceutical Chemistry
Introduction
Elizabeth Margaret Moir is a notable inventor based in Newhouse, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of heterocyclic derivatives for therapeutic applications. With a total of 2 patents, her work focuses on enhancing synaptic responses mediated by AMPA receptors, which are crucial in treating various psychiatric diseases.
Latest Patents
Moir's latest patents include innovative compounds such as substituted thieno[2,3-d]pyrimidines, which serve as AMPA modulators. These inventions relate to heterocyclic derivatives that can be utilized in pharmaceutical compositions aimed at treating psychiatric conditions like schizophrenia, depression, and Alzheimer's disease. The patents emphasize the importance of these compounds in enhancing synaptic responses, thereby offering potential therapeutic benefits.
Career Highlights
Throughout her career, Elizabeth has worked with prominent companies in the pharmaceutical industry, including N.V. Organon and MSD Oss B.V. Her experience in these organizations has allowed her to develop her expertise in drug formulation and therapeutic applications.
Collaborations
Moir has collaborated with notable professionals in her field, including Craig Jamieson and John Kinnaird Ferguson MacLean. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Elizabeth Margaret Moir stands out as a pioneering inventor in pharmaceutical chemistry, with her patents reflecting her commitment to advancing treatments for psychiatric diseases. Her contributions continue to impact the field positively.